Market Tracker

06/22 5:15pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

8.49
Delayed Data
As of Jun 22
 +0.02 / +0.24%
Today’s Change
4.60
Today|||52-Week Range
9.12
+42.69%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close8.47
Today’s open8.46
Day’s range8.31 - 8.50
Volume1,966,486
Average volume (3 months)1,282,044
Market cap$548.5M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-586.67%
Earnings growth (this year)+22.83%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-83.15%
P/E ratioNM
Price/Sales35.75
Price/Book8.11

Competitors

 Today’s
change
Today’s
% change
ABEOAbeona Therapeutics ...+0.60+3.80%
ASMBAssembly Biosciences...-1.53-3.35%
KPTIKaryopharm Therapeut...-0.15-0.80%
CMTAClementia Pharmaceut...+1.21+8.40%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 10, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$11.7M
Annual profit (last year)-$51.0M
Net profit margin-436.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
CFO, Principal Accounting Officer &
Senior VP
Patrick Fabbio
Corporate headquarters
New York, New York

Forecasts